Capricor Therapeutics (4LN2) Q4 2024 Earnings Report
DE:4LN2 Q4 2024 EPS Results
- Actual EPS
- -EUR 0.14
- Consensus EPS
- -EUR 0.15
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- -EUR 0.02
DE:4LN2 Q4 2024 Revenue Results
- Actual Revenue
- EUR 9.97M
- Expected Revenue
- EUR 10.31M
- Beat/Miss
- Missed by -EUR 344.27K
- YoY Revenue Growth
- -7.92%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 03/19/2025
- Time
- After Close
- Conference Call
- Wednesday, March 19, 2025
DE:4LN2 Upcoming Earnings
Capricor Therapeutics's next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q4 2024 Earnings Call Audio
DE:4LN2 Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4LN2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | -0.11- | -0.48 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -0.53-0.63 | -0.51 | -22.81% (-0.12) | |
| May 12, 2026 | 2026 (Q1) | -0.47-0.53 | -0.47 | -11.32% (-0.05) | |
| Mar 12, 2026 | 2025 (Q4) | -0.46-0.56 | -0.14 | -287.50% (-0.41) | |
| Nov 10, 2025 | 2025 (Q3) | -0.49-0.48 | -0.34 | -42.11% (-0.14) | |
| Aug 11, 2025 | 2025 (Q2) | -0.43-0.51 | -0.31 | -62.86% (-0.20) | |
| May 13, 2025 | 2025 (Q1) | -0.28-0.47 | -0.28 | -70.97% (-0.20) | |
| Mar 19, 2025 | 2024 (Q4) | -0.15-0.14 | -0.02 | -700.00% (-0.13) | |
| Nov 13, 2024 | 2024 (Q3) | -0.32-0.34 | -0.22 | -52.00% (-0.12) | |
| Aug 07, 2024 | 2024 (Q2) | -0.32-0.31 | -0.26 | -20.69% (-0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
